Roche
RO.SW
#43
Rank
NZ$628.03 B
Marketcap
NZ$788.23
Share price
1.83%
Change (1 day)
22.74%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2025: NZ$36.41

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$36.41. In 2025 the company made an earnings per share (EPS) of NZ$36.41 an increase over its 2024 EPS that were of NZ$20.49.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025NZ$36.4177.67%
2024NZ$20.49-32.84%
2023NZ$30.511.95%
2022NZ$29.93-6.29%
2021NZ$31.94-5.53%
2020NZ$33.8116.56%
2019NZ$29.0030.3%
2018NZ$22.2620.22%
2017NZ$18.51-5.81%
2016NZ$19.664.62%
2015NZ$18.79-5.13%
2014NZ$19.80-25.05%
2013NZ$26.4221.73%
2012NZ$21.713.82%
2011NZ$20.918.16%
2010NZ$19.3323.72%
2009NZ$15.62-12.31%
2008NZ$17.82-0.34%
2007NZ$17.8832.13%
2006NZ$13.5342.56%
2005NZ$9.49-22.7%
2004NZ$12.28132.85%
2003NZ$5.27-151.22%
2002NZ-$10.29-209.09%
2001NZ$9.44-57.03%
2000NZ$21.9653.29%
1999NZ$14.3231.24%
1998NZ$10.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.56-57.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.86-67.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$5.55-84.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$28.89-20.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.39-90.69%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$6.41-82.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$2.25-93.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.70-84.35%๐Ÿ‡ฌ๐Ÿ‡ง UK